Citadel Advisors’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Citadel Advisors’s Portfolio SKBI Stock Details SKBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-18,296	Closed	-$17K	–	9643
2015 Q3	$17K	Buy	+18,296	New	+$29.3K	﹤0.01%	8283

Other funds holding SKBI

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Citadel Advisors's SKBI Position: Q4 2015 in Review

Citadel Advisors sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2015, closing a stake of 18,296 shares — an estimated $17K sold.

Citadel Advisors first reported a position in SKBI in Q3 2015 and held it in 1 quarter. The position peaked at $17K in Q3 2015. 1 fund tracked by Wall St. Rank holds SKBI as of Q4 2015.

Citadel Advisors reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2015 after selling out during the quarter.
Citadel Advisors sold 18,296 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2015, an estimated $17K.
Citadel Advisors first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q3 2015 and held it in 1 quarter.
Citadel Advisors's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $17K in Q3 2015.
1 fund tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2015.

Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.